Cite
HARVARD Citation
Derfuss, T. et al. (2020). The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis. Multiple sclerosis journal, experimental, translational and clinical. 6 (1), p. . [Online].